Simran K Bhandari
Overview
Explore the profile of Simran K Bhandari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flagg M, Bhandari S, Pak K, Zhou H, Shaw S, Shi J, et al.
Mayo Clin Proc
. 2025 Feb;
PMID: 39969453
Objective: To compare dialysis transition patterns of chronic kidney disease (CKD) patients with heart failure (HF) and without HF, including inpatient "crash start" initiation of long-term ("maintenance") dialysis, early dialysis...
2.
Sim J, Chen Q, Cannizzaro N, Bhandari S, Fernandes A, Chang J, et al.
Am J Nephrol
. 2024 Nov;
:1-6.
PMID: 39496243
Introduction: IgA nephropathy (IgAN), a leading cause of kidney failure worldwide, is one of the most common forms of primary glomerulonephropathy with variability by race and ethnicity. Using a diverse...
3.
Munis M, Chen Q, Hill T, Zhuo M, Schachter A, Bhandari S, et al.
Clin J Am Soc Nephrol
. 2024 Oct;
PMID: 39392691
No abstract available.
4.
Sim J, Shu Y, Bhandari S, Chen Q, Harrison T, Lee M, et al.
PLoS One
. 2024 Jun;
19(6):e0298484.
PMID: 38837988
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic kidney disease with high phenotypic variability. Furthering insights into patients' ADPKD progression could lead to earlier detection, management, and alter the...
5.
Aung T, Bhandari S, Chen Q, Malik F, Willey C, Reynolds K, et al.
Kidney360
. 2022 Apr;
2(12):2010-2015.
PMID: 35419536
Among a large racially and ethnically diverse US population, the prevalence of diagnosed ADPKD between 2002 and 2018 was 42.6 per 100,000 persons.ADPKD prevalence (per 100,000) was higher in (non-Hispanic)...
6.
Bhandari S, Zhou H, Shaw S, Shi J, Tilluckdharry N, Rhee C, et al.
Am J Nephrol
. 2022 Jan;
53(1):32-40.
PMID: 35016183
Introduction: Using a large diverse population of incident end-stage kidney disease (ESKD) patients from an integrated health system, we sought to evaluate the concordance of causes of death (CODs) between...
7.
Bhandari S, Adams A, Li B, Rhee C, Sundar S, Krasa H, et al.
Intern Med J
. 2019 Nov;
50(9):1100-1108.
PMID: 31707754
Background: Falls and hip fractures among older people are associated with high morbidity and mortality. Hyponatraemia may be a risk for falls/hip fractures, but the effect of hyponatraemia duration is...
8.
Zhou H, Sim J, Bhandari S, Shaw S, Shi J, Rasgon S, et al.
Kidney Int Rep
. 2019 Feb;
4(2):275-284.
PMID: 30775624
Introduction: Lower early mortality observed in peritoneal dialysis (PD) compared with hemodialysis (HD) may be due to differential pre-end-stage renal disease (ESRD) care and the stable setting of transition to...
9.
Sim J, Bhandari S, Batech M, Hever A, Harrison T, Shu Y, et al.
Mayo Clin Proc
. 2018 Feb;
93(2):167-178.
PMID: 29395351
Objective: To compare renal function decline, incident end-stage renal disease (ESRD), and mortality among patients with 5 common glomerular diseases in a large diverse population. Patients And Methods: A retrospective...
10.
Bhandari S, Liu I, Kujubu D, Huynh T, Behayaa H, Kovesdy C, et al.
Am J Nephrol
. 2017 Apr;
45(5):431-441.
PMID: 28445887
Background: Whether the benefits of phosphorus binders extend to those without end stage renal disease is uncertain. Among a large diverse non-dialysis chronic kidney disease (CKD) population with hyperphosphatemia, we...